187 related articles for article (PubMed ID: 23349498)
1. Link between GIP and osteopontin in adipose tissue and insulin resistance.
Ahlqvist E; Osmark P; Kuulasmaa T; Pilgaard K; Omar B; Brøns C; Kotova O; Zetterqvist AV; Stancáková A; Jonsson A; Hansson O; Kuusisto J; Kieffer TJ; Tuomi T; Isomaa B; Madsbad S; Gomez MF; Poulsen P; Laakso M; Degerman E; Pihlajamäki J; Wierup N; Vaag A; Groop L; Lyssenko V
Diabetes; 2013 Jun; 62(6):2088-94. PubMed ID: 23349498
[TBL] [Abstract][Full Text] [Related]
2. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.
Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S
J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of GIP on islet function involve osteopontin.
Lyssenko V; Eliasson L; Kotova O; Pilgaard K; Wierup N; Salehi A; Wendt A; Jonsson A; De Marinis YZ; Berglund LM; Taneera J; Balhuizen A; Hansson O; Osmark P; Dunér P; Brøns C; Stancáková A; Kuusisto J; Bugliani M; Saxena R; Ahlqvist E; Kieffer TJ; Tuomi T; Isomaa B; Melander O; Sonestedt E; Orho-Melander M; Nilsson P; Bonetti S; Bonadonna R; Miccoli R; Delprato S; Marchetti P; Madsbad S; Poulsen P; Vaag A; Laakso M; Gomez MF; Groop L
Diabetes; 2011 Sep; 60(9):2424-33. PubMed ID: 21810601
[TBL] [Abstract][Full Text] [Related]
4. Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice.
Chen S; Okahara F; Osaki N; Shimotoyodome A
Am J Physiol Endocrinol Metab; 2015 Mar; 308(5):E414-25. PubMed ID: 25537494
[TBL] [Abstract][Full Text] [Related]
5. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial.
Gögebakan Ö; Osterhoff MA; Schüler R; Pivovarova O; Kruse M; Seltmann AC; Mosig AS; Rudovich N; Nauck M; Pfeiffer AF
Diabetologia; 2015 Aug; 58(8):1759-68. PubMed ID: 25994074
[TBL] [Abstract][Full Text] [Related]
6. Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.
Berglund LM; Lyssenko V; Ladenvall C; Kotova O; Edsfeldt A; Pilgaard K; Alkayyali S; Brøns C; Forsblom C; Jonsson A; Zetterqvist AV; Nitulescu M; McDavitt CR; Dunér P; Stancáková A; Kuusisto J; Ahlqvist E; Lajer M; Tarnow L; Madsbad S; Rossing P; Kieffer TJ; Melander O; Orho-Melander M; Nilsson P; Groop PH; Vaag A; Lindblad B; Gottsäter A; Laakso M; Goncalves I; Groop L; Gomez MF
Diabetes; 2016 Jan; 65(1):239-54. PubMed ID: 26395740
[TBL] [Abstract][Full Text] [Related]
7. Long-acting glucose-dependent insulinotropic polypeptide ameliorates obesity-induced adipose tissue inflammation.
Varol C; Zvibel I; Spektor L; Mantelmacher FD; Vugman M; Thurm T; Khatib M; Elmaliah E; Halpern Z; Fishman S
J Immunol; 2014 Oct; 193(8):4002-9. PubMed ID: 25217161
[TBL] [Abstract][Full Text] [Related]
8. A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.
Mohammad S; Patel RT; Bruno J; Panhwar MS; Wen J; McGraw TE
Mol Cell Biol; 2014 Oct; 34(19):3618-29. PubMed ID: 25047836
[TBL] [Abstract][Full Text] [Related]
9. Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes.
Timper K; Grisouard J; Sauter NS; Herzog-Radimerski T; Dembinski K; Peterli R; Frey DM; Zulewski H; Keller U; Müller B; Christ-Crain M
Am J Physiol Endocrinol Metab; 2013 Jan; 304(1):E1-13. PubMed ID: 23092914
[TBL] [Abstract][Full Text] [Related]
10. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
[TBL] [Abstract][Full Text] [Related]
11. The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD).
Thondam SK; Cuthbertson DJ; Wilding JPH
Peptides; 2020 Mar; 125():170208. PubMed ID: 31759125
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the pro-inflammatory cytokine osteopontin by GIP in adipocytes--a role for the transcription factor NFAT and phosphodiesterase 3B.
Omar B; Banke E; Guirguis E; Åkesson L; Manganiello V; Lyssenko V; Groop L; Gomez MF; Degerman E
Biochem Biophys Res Commun; 2012 Sep; 425(4):812-7. PubMed ID: 22892131
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.
Joo E; Harada N; Yamane S; Fukushima T; Taura D; Iwasaki K; Sankoda A; Shibue K; Harada T; Suzuki K; Hamasaki A; Inagaki N
Diabetes; 2017 Apr; 66(4):868-879. PubMed ID: 28096257
[TBL] [Abstract][Full Text] [Related]
14. Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus.
Fu Y; Kaneko K; Lin HY; Mo Q; Xu Y; Suganami T; Ravn P; Fukuda M
Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32603429
[TBL] [Abstract][Full Text] [Related]
15. GIP biology and fat metabolism.
Yip RG; Wolfe MM
Life Sci; 2000; 66(2):91-103. PubMed ID: 10666005
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice.
Chapman J; Miles PD; Ofrecio JM; Neels JG; Yu JG; Resnik JL; Wilkes J; Talukdar S; Thapar D; Johnson K; Sears DD
PLoS One; 2010 Nov; 5(11):e13959. PubMed ID: 21103061
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional factor Pdx1 is involved in age-related GIP hypersecretion in mice.
Ikeguchi E; Harada N; Kanemaru Y; Sankoda A; Yamane S; Iwasaki K; Imajo M; Murata Y; Suzuki K; Joo E; Inagaki N
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G272-G282. PubMed ID: 29723041
[TBL] [Abstract][Full Text] [Related]
18. Role of glucose-dependent insulinotropic polypeptide in adipose tissue inflammation of dipeptidylpeptidase 4-deficient rats.
Ben-Shlomo S; Zvibel I; Varol C; Spektor L; Shlomai A; Santo EM; Halpern Z; Oren R; Fishman S
Obesity (Silver Spring); 2013 Nov; 21(11):2331-41. PubMed ID: 23408696
[TBL] [Abstract][Full Text] [Related]
19. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet.
McClean PL; Irwin N; Cassidy RS; Holst JJ; Gault VA; Flatt PR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1746-55. PubMed ID: 17848629
[TBL] [Abstract][Full Text] [Related]
20. GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
Boer GA; Keenan SN; Miotto PM; Holst JJ; Watt MJ
Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E835-E845. PubMed ID: 33645252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
